A detailed history of Wexford Capital LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Wexford Capital LP holds 1,871 shares of LLY stock, worth $1.49 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,871
Holding current value
$1.49 Million
% of portfolio
0.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1.44 Million - $1.8 Million
1,871 New
1,871 $1.66 Million
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $2.8 Million - $3.3 Million
5,335 New
5,335 $3.11 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $592 - $675
2 Added 0.25%
813 $263,000
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $557 - $654
2 Added 0.25%
811 $263,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $189,864 - $235,952
809 New
809 $232,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wexford Capital LP Portfolio

Follow Wexford Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.